Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Metformin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 8 Brain Neoplasms 5 Neoplasms 4 Glioma 3 Medulloblastoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Ketosis 1 Insulin Resistance 1 Gliosarcoma 1 Diabetes Mellitus 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Chondrosarcoma 1 Cholangiocarcinoma 1 Astrocytoma 1

Interventions

Patient Reported Outcome Measures 2 Neuropsychological Tests 2 lithium sulfate 1 XENP 1595 1 Tablets 1 Sodium Chloride 1 Ramipril 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Quality of Life 1 Pioglitazone 1 Metformin 1 Mental Status and Dementia Tests 1 Memantine 1 Lithium 1 G(M1) Ganglioside 1 Donepezil 1 Climate Anxiety 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡